Company Profile

Company Profile

Royal Philips of the Netherlands is a diversified technology company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. The company is a leader in cardiac care, acute care and home healthcare, energy-efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare.

Brand-Campaign-key-visual-275x90.jpg

Creating innovations that matter to people

"Since the introduction of the first Philips light bulb more than 120 years ago, innovation and a people-centric approach have always been at the core of our company.
 
Our commitment is to deliver new healthcare and lighting technologies, as well as innovative and locally relevant consumer products that make a real difference to our customers, consumers and stakeholders across the globe. We believe that the best way for us to do this is through deep understanding of people's needs and desires.
 
When we bring people and innovation together, we create the next generation of technology and things that people truly want and need. These are meaningful innovations that help people to be healthy, live well and enjoy life. This sets us apart and makes us Philips."

Company Business highlights Q4

Business Highlights in Q4

Expanding its global leadership position in image-guided therapies, Philips has entered into an agreement to acquire Volcano Corporation, a global leader in catheter-based imaging and measurement solutions for cardiovascular applications. Volcano’s complementary portfolio and expertise will create opportunities to accelerate revenue growth for Philips' image-guided therapy business.

Continuing its focus on long-term partnerships with large organizations, Philips signed patient monitoring and software maintenance agreements for all Mayo Clinic owned hospitals. These agreements include hardware and software solutions, as well as a number of services.


On China’s biggest day of the year for online shopping, ‘Double 11’, Philips held leading market\ positions in the Male Grooming, Oral Healthcare and Mother & Child Care categories. Sales grew 40% year-on-year, driven by dedicated digital campaigns and partnerships with the largest online sales platforms.

 

Philips Oral Healthcare reported continued growth globally, with Philips Sonicare delivering record market share growth, driven by advanced\ propositions endorsed by dental professionals and celebrities, as well as collaboration with key retailers. The new Philips Sonicare 2 Series was well received by consumers in North America and was rated 4.2 out of 5 in online reviews.


Philips is to provide the city of Madrid, Spain with 225,000 energy-efficient street lights. The renewal of the city’s entire street lighting system makes it the world’s largest street lighting upgrade to date.

Designed for the high-end retail market, Philips’ connected ambient lighting system will light up Lexus\ showrooms across Russia. The innovative system combines LEDs with textile and dynamic content.

Philips reached an important milestone in the development of its emerging Digital Pathology business by obtaining the CE mark to market its Digital Pathology Solution in Europe for routine diagnostic use, such as the diagnosis of cancer. This follows the FDA clearance for Philips’ digital manual read of HER2 pathology slides, which is used in the diagnosis of certain breast cancers.

Reflecting its continued commitment to sustainability, Philips inaugurated a healthcare imaging systems refurbishment facility in Best, the Netherlands. This facility brings the financial and environmental benefits of circular economy to the healthcare industry. Philips was also recognized, for the third consecutive year, as a leader in both carbon disclosure and performance by the Carbon Disclosure Project.

 
Circular Economy

Philips’ transition to a Circular Economy


 
 
Philips in Q4 2014

Sales                              6.5 bln

Adjusted EBITA           743 mln

Net income                   134 mln